Ejenta
Ejenta is a San Francisco-based AI healthcare company that provides an agentic connected care platform for remote patient monitoring of chronic disease patients, built on AI technology licensed from NASA. It serves enterprise healthcare payers, providers, and government agencies including NASA.
- Company typePrivate
- Founded2012
- HeadquartersLos Angeles, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Ejenta does
Ejenta is a private, San Francisco-based healthcare technology company founded in 2012 that builds an Agentic Connected Care platform for AI-powered remote patient monitoring and chronic disease management. The platform is built on AI technology exclusively licensed from NASA, including the Brahms agent-oriented programming language (a Belief-Desire-Intention cognitive architecture) originally developed at NASA Ames Research Center, which has run 24/7 in NASA's Mission Control for the International Space Station since 2008 via the OCAMS system. Intelligent agents integrate data from wearable sensors, IoT devices (Withings, BodyTrace), and electronic health records to monitor patients continuously, predict health deterioration, and coordinate care teams autonomously. The product portfolio includes the core connected care platform, the Ejenta mobile app with voice and chat interfaces, the Brahms developer environment, and the Crew Medical Officer Digital Assistant (CMO-DA) — a specialized LLM developed with NASA and Google for clinical decision support in deep space missions.
Ejenta serves enterprise healthcare buyers — primarily health insurers and payers, healthcare providers and academic medical systems, and U.S. government agencies including NASA and the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine. Named engagements include a congestive heart failure remote monitoring pilot with Point32Health (parent of Harvard Pilgrim Health Care and Tufts Health Plan), clinical validation with Mass General Brigham, and ongoing space health collaborations with NASA Human Research Program and Google. The company generates revenue through subscription-based SaaS platform licensing to healthcare organizations and professional services agreements for space health technology development, though no pricing, ARR, or contract values are publicly disclosed.
The company operates with a very small team (1-10 employees) and has not raised a disclosed priced equity funding round, instead relying on a series of accelerator programs (Techstars, Alchemist, AWS Healthcare Accelerator, Amazon Alexa Fund, Starburst, MassChallenge, 500 Global, Yamaha Motor Ventures, Dreamit Healthtech) and research grants. Ejenta's leadership — co-founder and CEO Rachna Dhamija (Ph.D.) and co-founder Maarten Sierhuis (former NASA Ames Senior Scientist and Brahms lead) — provides deep institutional expertise in agent-oriented AI systems. Recent recognition includes Best in Show at HIMSS26 (March 2026) for Total Cost of Care Reduction for Payers and an AWS Healthcare Accelerator finalist selection in 2021.
Ejenta firmographics
Firmographics- Name
- Ejenta
- Legal name
- Ejenta, Inc.
- Website
- https://ejenta.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ejenta is a San Francisco-based AI healthcare company that provides an agentic connected care platform for remote patient monitoring of chronic disease patients, built on AI technology licensed from NASA. It serves enterprise healthcare payers, providers, and government agencies including NASA.
- Ownership category
- akta.pro rank
Ejenta industry classification
Industry- Product category
- Healthcare AI / Remote Patient Monitoring Software
- NAICS
- Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)
- akta.pro industry
- Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF)Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care PlatformsAI/Analytics for RPM (Risk Stratification, Alerts, Predictive)Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
Keywords
Where Ejenta is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Ejenta business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Remote Patient Monitoring Platform: Subscription-based SaaS platform for healthcare organizations to automate remote monitoring and care delivery. Revenue derived from platform licensing and monitoring services to health insurers, providers, and government health agencies.
- Space Health Technology Services: Service agreements with NASA/TRISH for integrating Ejenta's platform with space health applications. Includes collaboration on AI tools for deep space crew health monitoring.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Ejenta product offering
Product offeringCore offering
Ejenta offers a cloud-based Agentic Connected Care Platform built on AI technology exclusively licensed from NASA. The platform uses intelligent agents running 24/7 to monitor patients, predict health deterioration from sensor/IoT/EHR data, and connect care teams across health insurers, providers, and government health agencies.
Product overview
Ejenta offers an Agentic Connected Care platform based on AI technology exclusively licensed from NASA. The core platform integrates medical devices and environmental sensors with a suite of intelligent agents running 24/7 in cloud and local environments. Users interact with their personal agents via multiple devices including mobile apps, spoken natural language, and chat interfaces. The product portfolio includes the core Agentic Connected Care platform for remote patient monitoring, the Crew Medical Officer Digital Assistant (CMO-DA) for space-based clinical decision support, the Brahms Agent Language and development environment for building intelligent agents, and the Ejenta Mobile App for end-user access. The Brahms Agent Language, originally developed at NASA Ames Research Center, is available via license for academic and commercial development.
Differentiator
Problem solved
Functional benefit
Brands
- Brahms: An Agent-Oriented Language for developing Intelligent Agents, originally developed at NASA and now made available through Ejenta's Brahms platform for academic and research use.
Products and services
- Agentic Connected Care Platform
Quantifiable outcome
- Best in Show at HIMSS26 for Total Cost of Care Reduction for Payers
- +2 more outcomes
Companies that use Ejenta
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Ejenta technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability6 records
Feature3 records
Ejenta partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, flagship and minor.
- NASA Human Research ProgramcoreEjenta collaborates with NASA's AI Team and Google to develop AI tools for clinical decision support in deep space missions. Through service agreement with TRISH, Ejenta provided its platform for integration with the Crew Medical Officer Digital Assistant (CMO-DA), demonstrating AI-guided ultrasound imaging for space medical operations.
- GooglecoreCollaborating with Google to optimize open-source LLM using Vertex AI platform trained on space medicine resources. Google provided AI infrastructure for developing specialized LLM in agentic configuration for NASA's Crew Medical Officer Digital Assistant.
- Mass General BrighamflagshipCEO Rachna Dhamija presented at Mass General Brigham MESH Core 2025 Conference on Agentic AI Platform results with Point32Health members with heart failure. Partnership for research and clinical validation of connected care platform.
- Amazon Web Services (AWS)flagshipAWS partnership for speaking engagements at HIMSS25. Joint presentation on 'Intelligent Agents for Connected Care: From Space to Earth' at AWS Booth. AWS Healthcare Accelerator alumnus providing cloud infrastructure for healthcare AI platform.
- TRISH (Translational Research Institute for Space Health)coreSelected by TRISH at Baylor College of Medicine (with consortium partners MIT and Caltech) to develop systems for healthcare delivery and data management for spaceflight participants and researchers. Service agreement administered for platform access and technology development.
- Point32HealthflagshipPoint32Health (parent of Harvard Pilgrim Health Care and Tufts Health Plan) piloted Ejenta remote monitoring system for congestive heart failure patients. Partnership to improve health and wellness through automated remote monitoring and care delivery.
- Baylor College of MedicinecoreTRISH host institution. Ejenta's Master Services Agreement with Baylor College of Medicine effective November 1, 2023 for space health research collaboration.
- Amazon Alexa AcceleratorminorGraduated from Amazon Alexa Accelerator program. Focus on voice-enabled remote patient healthcare applications using Alexa integration.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Ejenta competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key highlights6 records
Customer concentration
Ejenta social profiles
Digital presenceEjenta financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ejenta leadership team
Management profileNumber of profiles
Profiles3 records
Ejenta funding detail
Funding detailFunding overview
Funding rounds9 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ejenta M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ejenta
What does Ejenta do?
Ejenta offers a cloud-based Agentic Connected Care Platform built on AI technology exclusively licensed from NASA. The platform uses intelligent agents running 24/7 to monitor patients, predict health deterioration from sensor/IoT/EHR data, and connect care teams across health insurers, providers, and government health agencies.
Is Ejenta a public or private company?
Ejenta is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ejenta founded?
Ejenta was founded in 2012. It employs 1 to 10 people.
Where is Ejenta based?
Ejenta is headquartered in Los Angeles, United States, in the North America region.
How does Ejenta make money?
Two revenue lines are on record. Remote Patient Monitoring Platform is the primary driver. The others are space Health Technology Services.
Does Ejenta have an API?
No public API is recorded for Ejenta.
What industry is Ejenta in?
Ejenta's product category is Healthcare AI / Remote Patient Monitoring Software. Its primary akta.pro industry code is HLACAFAA, Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF), with a secondary code of HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive). Its NAICS code is 541512 and its SIC code is 7370.